SynthesisInternational journal of chronic obstructive pulmonary disease2012

Once-daily glycopyrronium bromide, a long-acting muscarinic antagonist, for chronic obstructive pulmonary disease: a systematic review of clinical benefit.

Charlotte Suppli UlrikPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.